 | Up a level |
Schoepfer, AM; Beglinger, C; Straumann, A; Trummler, M; Renzulli, P; Seibold, F (2009). Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflammatory bowel diseases, 15(12), pp. 1851-1858. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20986
Schoepfer, A; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2008). Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflammatory bowel diseases, 14(1), pp. 32-39. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20275
Schoepfer, AM; Trummler, M; Seeholzer, P; Criblez, D; Seibold, F (2007). Accuracy of Four Fecal Assays in the Diagnosis of Colitis. Diseases of the colon & rectum, 50(10), pp. 1697-1706. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1007/s10350-007-0303-9
Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Discriminating IBD from IBS: a Comparative Evaluation of the Test Performance of Fecal Markers and IBD Antibodies. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 5S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Biomarkers for Discrimination of IBD versus IBS: Accuracy of Fecal Leucocyte Markers is improved when combined with IBD Antibody Panels. Journal of Crohn's & Colitis(1), AP13. Amsterdam: Elsevier
Schoepfer, A; Trummler, M; Seibold, B; Seeholzer, P; Seibold, F (2006). Accuracy of four fecal markers in inflammatory colonic disease. Poster präsentiert am DDW Los Angeles Mai 2006. Gastroenterology(130), A217. Philadelphia, Pa.: Elsevier
Schoepfer, A; Trummler, M; Seibold, B; Seeholzer, P; Seibold, F (2006). Diagnosis of Inflammatory Bowel Disease: which Laboratory Parameter helps the most? Gastroenterology(130), A208. Philadelphia, Pa.: Elsevier
